Conditions: Glaucoma
Keywords: Glaucoma IOP Travoprost
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 51
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and efficacy of Travoprost 0.004% and Tafluprost 0.0015% in patients with primary open angle glaucoma or ocular hypertension when both medications are administered in the evening.

Detailed description:

Arms:
arm 1: Travoprost first, with tafluprost second. Each product dosed for six weeks. arm 2: Tafluprost first, with travoprost second. Each product dosed for six weeks.

Interventions: intervention 1: Travoprost 0.004% ophthalmic solution (TRAVATAN) intervention 2: Tafluprost 0.0015% ophthalmic solution
Intervention descriptions: intervention 1: One drop in the qualifying eye(s) each evening at 6:00 PM for 6 weeks, topical administration intervention 2: One drop in the qualifying eye(s) each evening at 6:00 PM for 6 weeks, topical administration

Protocol document: